NASDAQ: SURG
Surgepays Inc Stock

$0.46-0.04 (-8%)
Updated Jun 10, 2026
SURG Price
$0.46
Fair Value Price
N/A
Market Cap
$11.53M
52 Week Low
$0.44
52 Week High
$3.45
P/E
-0.24x
P/B
-0.48x
P/S
0.29x
PEG
N/A
Dividend Yield
N/A
Revenue
$62.37M
Earnings
-$40.48M
Gross Margin
-24.6%
Operating Margin
-60.48%
Profit Margin
-64.9%
Debt to Equity
-1.4
Operating Cash Flow
-$19M
Beta
0.77
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

SURG Overview

SurgePays, Inc. operates as a financial technology and telecommunications enterprise dedicated to serving the underbanked communities across the United States. A core component of its strategy is a blockchain-powered platform that transforms local corner stores and bodegas into vital technology hubs, providing a suite of financial and prepaid products. In its telecommunications division, the company delivers voice and SMS messaging services to subsidized, direct retail prepaid, and low-income subscribers. Furthermore, it offers subsidized mobile broadband connectivity to consumers in California, Colorado, Florida, Illinois, Maryland, Mississippi, Missouri, Nevada, New Jersey, Ohio, Oklahoma, Rhode Island, Tennessee, and Texas, alongside traditional prepaid wireless options. Beyond these primary offerings, SurgePays also extends specialized services to law firms in the mass tort industry, including marketing business intelligence, plaintiff generation, and caseload management solutions. To support its diverse operations, the company maintains a bilingual operations center that provides essential internal functions such as sales assistance, customer service, IT infrastructure design, graphic media, database programming, software development, revenue assurance, and lead generation. The company's headquarters are located in Bartlett, Tennessee.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine SURG's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: App

Industry Rating
B
SURG
Ranked
Unranked of 173

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$1.72A
$2.68A
$38.73A
View Top App Stocks

Be the first to know about important SURG news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SURG scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SURG is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SURG is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
SURG's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more SURG due diligence checks available for Premium users.

Valuation

SURG price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.24x
Industry
52.26x
Market
14.77x

SURG price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
-0.48x
Industry
4.99x

SURG's financial health

Profit margin

Revenue
$16.0M
Net Income
-$12.1M
Profit Margin
-75.4%
SURG's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SURG's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$9.5M
Liabilities
$33.4M
Debt to equity
-1.4
SURG's short-term liabilities ($30.04M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SURG's short-term assets ($8.21M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SURG's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SURG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.6M
Investing
$0.0
Financing
$5.0M
SURG's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SURG vs App Stocks

TickerZen RatingMarket Cap1d %P/EP/B
SURG$11.53M-8.20%-0.24x-0.48x
IDAI$11.54M-3.29%-0.93x1.61x
YAAS$11.26M+12.25%-0.96x1.37x
ANYD$12.14M-8.04%-0.53x0.61x
JTAIF$10.52M-5.25%0.01x0.29x

Surgepays Stock FAQ

What is Surgepays's quote symbol?

(NASDAQ: SURG) Surgepays trades on the NASDAQ under the ticker symbol SURG. Surgepays stock quotes can also be displayed as NASDAQ: SURG.

If you're new to stock investing, here's how to buy Surgepays stock.

What is the 52 week high and low for Surgepays (NASDAQ: SURG)?

(NASDAQ: SURG) Surgepays's 52-week high was $3.45, and its 52-week low was $0.44. It is currently -86.7% from its 52-week high and 4.32% from its 52-week low.

How much is Surgepays stock worth today?

(NASDAQ: SURG) Surgepays currently has 25,121,895 outstanding shares. With Surgepays stock trading at $0.46 per share, the total value of Surgepays stock (market capitalization) is $11.53M.

Surgepays stock was originally listed at a price of $59.50 in Jan 17, 2018. If you had invested in Surgepays stock at $59.50, your return over the last 8 years would have been -99.23%, for an annualized return of -45.56% (not including any dividends or dividend reinvestments).

How much is Surgepays's stock price per share?

(NASDAQ: SURG) Surgepays stock price per share is $0.46 today (as of Jun 10, 2026).

What is Surgepays's Market Cap?

(NASDAQ: SURG) Surgepays's market cap is $11.53M, as of Jun 12, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Surgepays's market cap is calculated by multiplying SURG's current stock price of $0.46 by SURG's total outstanding shares of 25,121,895.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.